Owen RG - Search Results

1

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.

Owen RG, Pratt G, Auer RL, Flatley R, Kyriakou C, Lunn MP, Matthey F, McCarthy H, McNicholl FP, Rassam SM, Wagner SD, Streetly M, D'Sa S; British Committee for Standards in Haematology. Owen RG, et al. Br J Haematol. 2014 May;165(3):316-33. doi: 10.1111/bjh.12760. Epub 2014 Feb 15. Br J Haematol. 2014. PMID: 24528152 Free article. No abstract available.

2

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors.

Rawstron AC, Davies FE, Owen RG, English A, Pratt G, Child JA, Jack AS, Morgan GJ. Rawstron AC, et al. Among authors: owen rg. Br J Haematol. 1998 Jan;100(1):176-83. doi: 10.1046/j.1365-2141.1998.00525.x. Br J Haematol. 1998. PMID: 9450807 Free article.

3

Waldenström's macroglobulinaemia: laboratory diagnosis and treatment.

Owen RG, Johnson SA, Morgan GJ. Owen RG, et al. Hematol Oncol. 2000 Jun;18(2):41-9. doi: 10.1002/1099-1069(200006)18:2<41::aid-hon654>3.0.co;2-w. Hematol Oncol. 2000. PMID: 10960874 Review. No abstract available.

4

Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma.

Pratt G, Fenton JA, Davies FE, Rawstron AC, Richards SJ, Collins JE, Owen RG, Jack AS, Smith GM, Morgan GJ. Pratt G, et al. Among authors: owen rg. Br J Haematol. 2001 Feb;112(2):388-91. doi: 10.1046/j.1365-2141.2001.02588.x. Br J Haematol. 2001. PMID: 11167836 Free article.

5

The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma.

Davies FE, Forsyth PD, Rawstron AC, Owen RG, Pratt G, Evans PA, Richards SJ, Drayson M, Smith GM, Selby PJ, Child JA, Morgan GJ. Davies FE, et al. Among authors: owen rg. Br J Haematol. 2001 Mar;112(3):814-9. doi: 10.1046/j.1365-2141.2001.02530.x. Br J Haematol. 2001. PMID: 11260088 Free article.

6

Rarity of IgH translocations in Waldenström macroglobulinemia.

Ackroyd S, O'Connor SJ, Owen RG. Ackroyd S, et al. Among authors: owen rg. Cancer Genet Cytogenet. 2005 Nov;163(1):77-80. doi: 10.1016/j.cancergencyto.2005.04.009. Cancer Genet Cytogenet. 2005. PMID: 16271961

7

Guidelines on the management of Waldenström macroglobulinaemia.

Johnson SA, Birchall J, Luckie C, Oscier DG, Owen RG; Haemato-Oncology Task Force of the British Committee for Standards in Haematology. Johnson SA, et al. Among authors: owen rg. Br J Haematol. 2006 Mar;132(6):683-97. doi: 10.1111/j.1365-2141.2005.05948.x. Br J Haematol. 2006. PMID: 16487169 Free article. Review. No abstract available.

8

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.

Rawstron AC, Jones RA, Ferguson C, Hughes G, Selby P, Reid C, Dalal S, Howard M, Smith G, Hillmen P, Owen RG, Jack AS. Rawstron AC, et al. Among authors: owen rg. Br J Haematol. 2007 Dec;139(5):845-8. doi: 10.1111/j.1365-2141.2007.06864.x. Epub 2007 Oct 25. Br J Haematol. 2007. PMID: 17970800 Free article.

9

IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).

Feyler S, O'Connor SJ, Rawstron AC, Subash C, Ross FM, Pratt G, Drayson MT, Ashcroft J, Cook G, Owen RG. Feyler S, et al. Among authors: owen rg. Br J Haematol. 2008 Mar;140(5):547-51. doi: 10.1111/j.1365-2141.2007.06969.x. Br J Haematol. 2008. PMID: 18275432 Free article.

10

Assessment of bone marrow response in Waldenström's macroglobulinemia.

Varghese AM, Rawstron AC, Ashcroft AJ, Moreton P, Owen RG. Varghese AM, et al. Among authors: owen rg. Clin Lymphoma Myeloma. 2009 Mar;9(1):53-5. doi: 10.3816/CLM.2009.n.013. Clin Lymphoma Myeloma. 2009. PMID: 19362973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page